PPLPHARMAPharmaceuticals
Piramal Pharma Ltd — Balance Sheet
₹136.54
+1.77%
Piramal Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.46 Cr | 0.49 Cr | 0.48 Cr | — | — |
| Ordinary Shares Number | 132.12 Cr | 131.80 Cr | 121.71 Cr | 121.70 Cr | — |
| Share Issued | 132.57 Cr | 132.29 Cr | 122.19 Cr | 121.70 Cr | — |
| Net Debt | 4.35K Cr | 4.20K Cr | 5.31K Cr | 3.80K Cr | — |
| Total Debt | 4.86K Cr | 4.71K Cr | 5.64K Cr | 4.13K Cr | — |
| Tangible Book Value | 4.04K Cr | 3.62K Cr | 2.33K Cr | 2.36K Cr | — |
| Invested Capital | 12.85K Cr | 12.47K Cr | 12.28K Cr | 10.72K Cr | — |
| Working Capital | 2.03K Cr | 1.10K Cr | 992.43 Cr | 1.03K Cr | — |
| Net Tangible Assets | 4.04K Cr | 3.62K Cr | 2.33K Cr | 2.36K Cr | — |
| Capital Lease Obligations | 136.20 Cr | 151.30 Cr | 132.31 Cr | 104.64 Cr | — |
| Common Stock Equity | 8.13K Cr | 7.91K Cr | 6.77K Cr | 6.70K Cr | — |
| Total Capitalization | 11.34K Cr | 10.40K Cr | 10.16K Cr | 9.32K Cr | — |
| Total Equity Gross Minority Interest | 8.13K Cr | 7.91K Cr | 6.77K Cr | 6.70K Cr | — |
| Stockholders Equity | 8.13K Cr | 7.91K Cr | 6.77K Cr | 6.70K Cr | — |
| Other Equity Interest | 62.16 Cr | 27.47 Cr | 5.58K Cr | 5.51K Cr | — |
| Retained Earnings | 1.05K Cr | 970.67 Cr | — | 862.38 Cr | 569.04 Cr |
| Additional Paid In Capital | 4.74K Cr | 4.72K Cr | — | 3.73K Cr | 3.25K Cr |
| Capital Stock | 1.32K Cr | 1.32K Cr | 1.19K Cr | 1.19K Cr | — |
| Common Stock | 1.32K Cr | 1.32K Cr | 1.19K Cr | 1.19K Cr | — |
| Total Liabilities Net Minority Interest | 7.55K Cr | 7.40K Cr | 7.75K Cr | 6.10K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 3.79K Cr | 3.03K Cr | 3.91K Cr | 3.07K Cr | — |
| Other Non Current Liabilities | 175.61 Cr | 167.90 Cr | 175.58 Cr | 153.76 Cr | — |
| Non Current Deferred Revenue | 175.61 Cr | 167.90 Cr | 175.58 Cr | — | — |
| Non Current Deferred Taxes Liabilities | 248.35 Cr | 229.18 Cr | 219.31 Cr | 192.01 Cr | — |
| Long Term Debt And Capital Lease Obligation | 3.31K Cr | 2.60K Cr | 3.49K Cr | 2.71K Cr | — |
| Long Term Capital Lease Obligation | 99.16 Cr | 117.99 Cr | 101.92 Cr | 86.20 Cr | — |
| Long Term Debt | 3.21K Cr | 2.48K Cr | 3.38K Cr | 2.62K Cr | — |
| Long Term Provisions | 48.66 Cr | 32.32 Cr | 20.68 Cr | 12.59 Cr | — |
| Current Liabilities | 3.77K Cr | 4.37K Cr | 3.84K Cr | 3.03K Cr | — |
| Other Current Liabilities | 46.14 Cr | 41.79 Cr | 25.55 Cr | 37.47 Cr | — |
| Current Deferred Taxes Liabilities | 9.61 Cr | 40.30 Cr | 3.54 Cr | 71.66 Cr | — |
| Current Debt And Capital Lease Obligation | 1.54K Cr | 2.11K Cr | 2.15K Cr | 1.42K Cr | — |
| Current Capital Lease Obligation | 37.04 Cr | 33.31 Cr | 30.39 Cr | 18.44 Cr | — |
| Current Debt | 1.51K Cr | 2.08K Cr | 2.12K Cr | 1.40K Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 253.00 Cr | 203.00 Cr | 238.64 Cr | 142.79 Cr | — |
| Current Provisions | 42.85 Cr | 43.57 Cr | 39.21 Cr | 33.81 Cr | — |
| Payables | 1.68K Cr | 1.62K Cr | 1.21K Cr | 1.05K Cr | — |
| Other Payable | 147.50 Cr | 83.21 Cr | 12.62 Cr | 24.08 Cr | — |
| Total Tax Payable | 9.61 Cr | 40.30 Cr | 3.54 Cr | 71.66 Cr | — |
| Accounts Payable | 1.53K Cr | 1.54K Cr | 1.19K Cr | 1.03K Cr | — |
| Total Assets | 15.68K Cr | 15.31K Cr | 14.52K Cr | 12.80K Cr | — |
| Total Non Current Assets | 9.88K Cr | 9.85K Cr | 9.69K Cr | 8.73K Cr | — |
| Other Non Current Assets | -0.01 Cr | 94.02 Cr | 0.01 Cr | 68.69 Cr | — |
| Non Current Prepaid Assets | 106.05 Cr | 114.85 Cr | 236.87 Cr | 89.20 Cr | — |
| Non Current Deferred Taxes Assets | 393.13 Cr | 386.50 Cr | 349.30 Cr | 297.27 Cr | — |
| Other Investments | 44.30 Cr | 34.94 Cr | 41.76 Cr | 36.95 Cr | — |
| Investmentin Financial Assets | 44.30 Cr | 34.94 Cr | 41.76 Cr | 95.57 Cr | — |
| Available For Sale Securities | 20.70 Cr | 20.83 Cr | 21.55 Cr | 95.57 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 44.30 Cr | 34.94 Cr | 41.76 Cr | — | — |
| Long Term Equity Investment | 226.79 Cr | 205.32 Cr | 170.11 Cr | 179.82 Cr | — |
| Investments In Other Ventures Under Equity Method | 226.79 Cr | 205.32 Cr | 170.11 Cr | 179.82 Cr | — |
| Investmentsin Associatesat Cost | 226.79 Cr | 205.32 Cr | — | 105.69 Cr | 3.92 Cr |
| Goodwill And Other Intangible Assets | 4.09K Cr | 4.29K Cr | 4.45K Cr | 4.34K Cr | — |
| Other Intangible Assets | 2.94K Cr | 3.17K Cr | 3.34K Cr | 3.31K Cr | — |
| Goodwill | 1.15K Cr | 1.12K Cr | 1.11K Cr | 1.03K Cr | — |
| Net PPE | 5.02K Cr | 4.82K Cr | 4.44K Cr | 3.72K Cr | — |
| Accumulated Depreciation | -2.81K Cr | -2.36K Cr | -1.95K Cr | -1.54K Cr | — |
| Gross PPE | 7.83K Cr | 7.18K Cr | 6.39K Cr | 5.25K Cr | — |
| Construction In Progress | 489.12 Cr | 565.70 Cr | 852.93 Cr | 673.15 Cr | — |
| Other Properties | 25.06 Cr | 13.53 Cr | 225.48 Cr | 178.52 Cr | — |
| Machinery Furniture Equipment | 4.76K Cr | 4.16K Cr | 3.65K Cr | 3.07K Cr | — |
| Buildings And Improvements | 2.12K Cr | 2.00K Cr | 1.62K Cr | 1.20K Cr | — |
| Land And Improvements | 446.16 Cr | 436.75 Cr | 261.34 Cr | 133.75 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 5.80K Cr | 5.46K Cr | 4.84K Cr | 4.07K Cr | — |
| Other Current Assets | 551.80 Cr | 511.02 Cr | 527.68 Cr | 462.90 Cr | — |
| Hedging Assets Current | 13.35 Cr | 0.00 | 23.16 Cr | 7.48 Cr | — |
| Restricted Cash | 132.48 Cr | 125.74 Cr | 111.97 Cr | 5.62 Cr | — |
| Prepaid Assets | 531.84 Cr | 508.63 Cr | 541.42 Cr | 466.31 Cr | — |
| Inventory | 2.31K Cr | 2.18K Cr | 1.68K Cr | 1.39K Cr | — |
| Finished Goods | 597.02 Cr | 453.75 Cr | 446.19 Cr | 344.04 Cr | — |
| Work In Process | 623.90 Cr | 525.76 Cr | 334.72 Cr | 322.40 Cr | — |
| Raw Materials | 1.09K Cr | 1.20K Cr | 900.46 Cr | 722.36 Cr | — |
| Other Receivables | 65.23 Cr | 16.26 Cr | 18.57 Cr | 39.96 Cr | — |
| Taxes Receivable | 6.36 Cr | — | — | — | — |
| Accounts Receivable | 2.35K Cr | 2.13K Cr | 1.80K Cr | 1.79K Cr | — |
| Allowance For Doubtful Accounts Receivable | -97.76 Cr | -109.93 Cr | -103.42 Cr | -54.52 Cr | — |
| Gross Accounts Receivable | 2.45K Cr | 2.24K Cr | 1.90K Cr | 1.84K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 391.87 Cr | 503.53 Cr | 659.65 Cr | 379.39 Cr | — |
| Other Short Term Investments | 22.89 Cr | 146.71 Cr | 464.06 Cr | 151.29 Cr | — |
| Cash And Cash Equivalents | 368.98 Cr | 356.82 Cr | 195.59 Cr | 228.10 Cr | — |
| Cash Financial | 368.98 Cr | 356.82 Cr | 195.59 Cr | 228.10 Cr | — |
| Tradeand Other Payables Non Current | — | — | 4.98 Cr | 0.40 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | 10.74 Cr | 6.59 Cr |
| Investmentsin Subsidiariesat Cost | — | — | — | 2.49K Cr | 1.59K Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Piramal Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.